Cargando…
The Impact of Muscarinic Receptor Antagonists on Airway Inflammation: A Systematic Review
Long-acting muscarinic receptor antagonists (LAMAs) are the cornerstone for the treatment of chronic obstructive pulmonary disease (COPD); furthermore, tiotropium is approved as add-on therapy in severe asthmatic patients. Accumulating evidence suggests that LAMAs may modulate airway contractility a...
Autores principales: | Calzetta, Luigino, Coppola, Angelo, Ritondo, Beatrice Ludovica, Matino, Matteo, Chetta, Alfredo, Rogliani, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886086/ https://www.ncbi.nlm.nih.gov/pubmed/33603353 http://dx.doi.org/10.2147/COPD.S285867 |
Ejemplares similares
-
Muscarinic receptor antagonists and airway inflammation: A systematic review on pharmacological models
por: Calzetta, Luigino, et al.
Publicado: (2022) -
The Impact of Monoclonal Antibodies on Airway Smooth Muscle Contractility in Asthma: A Systematic Review
por: Calzetta, Luigino, et al.
Publicado: (2021) -
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review
por: Calzetta, Luigino, et al.
Publicado: (2022) -
Long-Acting Muscarinic Antagonists Under Investigational to Treat Chronic Obstructive Pulmonary Disease
por: Ora, Josuel, et al.
Publicado: (2020) -
Investigational Treatments in Phase I and II Clinical Trials: A Systematic Review in Asthma
por: Calzetta, Luigino, et al.
Publicado: (2022)